(Updated - December 22, 2025 7:25 AM EST)

Needham analyst Serge Belanger raised the price target on Cytokinetics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE